BRIEF-‍Indivior Says FDA Accepts Application For New Schizophrenia Drug
Dec 12 (Reuters) - Indivior Plc:
* ‍INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT​
* ‍U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED NEW DRUG APPLICATION (NDA) FOR RBP-7000​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)